종양학 영양 시장 : 시장 분석 및 예측 - 유형별, 제품별, 서비스별, 기술별, 용도별, 형태별, 최종 사용자별, 솔루션별, 단계별(-2035년)

Oncology Nutrition Market is anticipated to expand from $3.0 billion in 2024 to $5.9 billion by 2034, growing at a CAGR of approximately 7%. The Oncology Nutrition Market encompasses nutritional products and services tailored for cancer patients, addressing malnutrition and supporting treatment. This market includes supplements, enteral nutrition, and dietary advice, focusing on enhancing patient outcomes and quality of life. Rising cancer prevalence and awareness of nutritional therapy's role in treatment efficacy are propelling market growth, with innovations in personalized nutrition and plant-based options gaining traction.

The Oncology Nutrition Market is experiencing significant growth, propelled by the rising prevalence of cancer and increasing awareness about the role of nutrition in patient recovery. The enteral nutrition segment is the top performer, driven by its effectiveness in providing essential nutrients to patients unable to consume food orally. Within this segment, tube feeding products are in high demand due to their convenience and effectiveness. Parenteral nutrition follows as the second-highest performing segment, particularly for patients with severe digestive issues. In this segment, amino acid solutions are gaining prominence, offering critical support for muscle maintenance and recovery. The market is also witnessing a surge in demand for personalized nutrition solutions, tailored to meet individual patient needs. This trend is further supported by advancements in nutritional genomics, enabling more precise dietary interventions. The integration of technology in monitoring and managing nutritional requirements is enhancing patient outcomes and driving market expansion.

The Oncology Nutrition Market is characterized by a dynamic landscape of market share distribution, with leading companies vying for dominance through innovative product launches and competitive pricing strategies. Notable advancements in nutritional formulations tailored for oncology patients underscore the industry's commitment to enhancing patient care. The market's competitive pricing is influenced by the need to balance affordability with the high costs of research and development. New product introductions are increasingly focused on personalized nutrition solutions, reflecting a shift towards patient-centric care. Competition in the Oncology Nutrition Market is intense, with key players continuously enhancing their portfolios to maintain a competitive edge. Regulatory influences, particularly in North America and Europe, are pivotal in shaping market dynamics, ensuring product efficacy and safety. The global market is witnessing a surge in strategic alliances and mergers, aimed at expanding geographical reach and technological capabilities. The regulatory landscape is increasingly stringent, necessitating compliance with evolving standards, which simultaneously drives innovation and market growth.

Geographical Overview:

The oncology nutrition market is witnessing varied growth across regions, each presenting unique opportunities. North America leads, driven by a high prevalence of cancer and increasing awareness of nutritional interventions. The region's advanced healthcare infrastructure supports market expansion, with a focus on personalized nutrition plans. Europe follows, propelled by rising cancer cases and robust healthcare policies promoting nutritional support for oncology patients. Strong collaborations between healthcare providers and nutrition companies enhance market dynamics. In the Asia Pacific, the market is expanding rapidly due to a growing cancer burden and increasing healthcare expenditure. Emerging economies like China and India are investing in healthcare infrastructure, creating lucrative opportunities for market players. Latin America shows potential, with rising awareness about oncology nutrition and improving healthcare systems. The Middle East & Africa region is also emerging, with increasing recognition of the role of nutrition in cancer care. Efforts to improve healthcare access and awareness are driving market growth in these regions.

The global oncology nutrition market is intricately influenced by tariffs, geopolitical tensions, and evolving supply chain dynamics. Japan and South Korea, with their advanced healthcare infrastructures, are investing in localized production to mitigate tariff impacts and ensure supply chain resilience. China is accelerating its development of domestic nutritional solutions amid trade restrictions, while Taiwan focuses on leveraging its robust biotech sector to enhance market offerings. The parent market is witnessing steady growth driven by rising cancer prevalence and nutritional awareness. By 2035, market evolution will hinge on technological advancements and regional collaborations. Middle East conflicts exacerbate global supply chain disruptions and energy price volatility, indirectly affecting production costs and distribution networks in these East Asian economies.

Key Trends and Drivers:

The Oncology Nutrition Market is experiencing robust growth, propelled by increasing cancer prevalence and heightened awareness of nutritional therapy in oncology care. Key trends include the integration of personalized nutrition plans tailored to individual patient needs, supported by advancements in genomics and metabolomics. This personalized approach is enhancing treatment outcomes and patient quality of life. Technological innovations in nutritional products are also driving market expansion. Enhanced formulations, such as those enriched with immune-boosting and anti-inflammatory ingredients, are gaining traction. Furthermore, the rise of telehealth platforms is facilitating wider access to oncology nutrition services, allowing for remote consultations and personalized dietary guidance. The market is further driven by a growing emphasis on holistic cancer care, where nutrition is recognized as a critical component of comprehensive treatment strategies. Opportunities abound in emerging markets, where increasing healthcare infrastructure and cancer awareness are opening new avenues for growth. Companies that offer innovative, evidence-based nutritional solutions are well-positioned to capitalize on these trends, ensuring continued market expansion.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by Form
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Solutions
• 2.9 Key Market Highlights by Stage

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Enteral Nutrition
  • 4.1.2 Parenteral Nutrition
  • 4.1.3 Oral Nutrition Supplements
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Nutritional Supplements
  • 4.2.2 Feeding Tubes
  • 4.2.3 Feeding Pumps
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Dietary Counseling
  • 4.3.2 Nutritional Assessment
  • 4.3.3 Meal Planning
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Smart Feeding Devices
  • 4.4.2 Telehealth Integration
  • 4.4.3 AI-based Nutritional Analysis
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Cancer Cachexia
  • 4.5.2 Chemotherapy Induced Nausea and Vomiting
  • 4.5.3 Surgery Recovery
• 4.6 Market Size & Forecast by Form (2020-2035)
  • 4.6.1 Powder
  • 4.6.2 Liquid
  • 4.6.3 Capsules
  • 4.6.4 Tablets
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Hospitals
  • 4.7.2 Home Care Settings
  • 4.7.3 Cancer Research Institutes
• 4.8 Market Size & Forecast by Solutions (2020-2035)
  • 4.8.1 Personalized Nutrition Plans
  • 4.8.2 Automated Dietary Tracking
• 4.9 Market Size & Forecast by Stage (2020-2035)
  • 4.9.1 Pre-treatment
  • 4.9.2 During Treatment
  • 4.9.3 Post-treatment

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Application
    • 5.2.1.6 Form
    • 5.2.1.7 End User
    • 5.2.1.8 Solutions
    • 5.2.1.9 Stage
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Application
    • 5.2.2.6 Form
    • 5.2.2.7 End User
    • 5.2.2.8 Solutions
    • 5.2.2.9 Stage
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Application
    • 5.2.3.6 Form
    • 5.2.3.7 End User
    • 5.2.3.8 Solutions
    • 5.2.3.9 Stage
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Application
    • 5.3.1.6 Form
    • 5.3.1.7 End User
    • 5.3.1.8 Solutions
    • 5.3.1.9 Stage
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Application
    • 5.3.2.6 Form
    • 5.3.2.7 End User
    • 5.3.2.8 Solutions
    • 5.3.2.9 Stage
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Application
    • 5.3.3.6 Form
    • 5.3.3.7 End User
    • 5.3.3.8 Solutions
    • 5.3.3.9 Stage
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Application
    • 5.4.1.6 Form
    • 5.4.1.7 End User
    • 5.4.1.8 Solutions
    • 5.4.1.9 Stage
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Application
    • 5.4.2.6 Form
    • 5.4.2.7 End User
    • 5.4.2.8 Solutions
    • 5.4.2.9 Stage
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Application
    • 5.4.3.6 Form
    • 5.4.3.7 End User
    • 5.4.3.8 Solutions
    • 5.4.3.9 Stage
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Application
    • 5.4.4.6 Form
    • 5.4.4.7 End User
    • 5.4.4.8 Solutions
    • 5.4.4.9 Stage
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Application
    • 5.4.5.6 Form
    • 5.4.5.7 End User
    • 5.4.5.8 Solutions
    • 5.4.5.9 Stage
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Application
    • 5.4.6.6 Form
    • 5.4.6.7 End User
    • 5.4.6.8 Solutions
    • 5.4.6.9 Stage
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Application
    • 5.4.7.6 Form
    • 5.4.7.7 End User
    • 5.4.7.8 Solutions
    • 5.4.7.9 Stage
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Application
    • 5.5.1.6 Form
    • 5.5.1.7 End User
    • 5.5.1.8 Solutions
    • 5.5.1.9 Stage
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Application
    • 5.5.2.6 Form
    • 5.5.2.7 End User
    • 5.5.2.8 Solutions
    • 5.5.2.9 Stage
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Application
    • 5.5.3.6 Form
    • 5.5.3.7 End User
    • 5.5.3.8 Solutions
    • 5.5.3.9 Stage
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Application
    • 5.5.4.6 Form
    • 5.5.4.7 End User
    • 5.5.4.8 Solutions
    • 5.5.4.9 Stage
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Application
    • 5.5.5.6 Form
    • 5.5.5.7 End User
    • 5.5.5.8 Solutions
    • 5.5.5.9 Stage
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Application
    • 5.5.6.6 Form
    • 5.5.6.7 End User
    • 5.5.6.8 Solutions
    • 5.5.6.9 Stage
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Application
    • 5.6.1.6 Form
    • 5.6.1.7 End User
    • 5.6.1.8 Solutions
    • 5.6.1.9 Stage
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Application
    • 5.6.2.6 Form
    • 5.6.2.7 End User
    • 5.6.2.8 Solutions
    • 5.6.2.9 Stage
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Application
    • 5.6.3.6 Form
    • 5.6.3.7 End User
    • 5.6.3.8 Solutions
    • 5.6.3.9 Stage
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Application
    • 5.6.4.6 Form
    • 5.6.4.7 End User
    • 5.6.4.8 Solutions
    • 5.6.4.9 Stage
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Application
    • 5.6.5.6 Form
    • 5.6.5.7 End User
    • 5.6.5.8 Solutions
    • 5.6.5.9 Stage

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Nestle Health Science
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Abbott Nutrition
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Fresenius Kabi
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 B. Braun Melsungen
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Danone Nutricia
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Meiji Holdings
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Baxter International
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Hormel Health Labs
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Victus Inc
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Nutricia Advanced Medical Nutrition
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Kate Farms
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Medtrition Inc
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Global Health Products
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Nutritional Resources
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Applied Medical Technology
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Hormel Foods Corporation
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Nestle Nutrition Institute
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Ajinomoto Cambrooke
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Nephew Nutrition
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Nutritional Medicinals
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us